All Stories

  1. How I Treat IgA Nephropathy
  2. Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium
  3. Magnesium Concentration in Dialysate: Is Higher Better?
  4. Sucroferric oxyhydroxide for the treatment of hyperphosphatemia
  5. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
  6. YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation
  7. Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial
  8. Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis
  9. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial
  10. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
  11. Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
  12. Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis Patients